Pneumologia
Estudo de coorte | Pacientes com Covid-19 infectados pela variante Delta são 2 vezes mais suscetíveis à necessidade de admissão hospitalar ou atendimento de emergência.
30 Ago, 2021 | 13:41hComentários:
Covid: Delta variant patients twice as likely to need hospital care – BBC
Covid-19 hospitalization risk doubles with Delta variant, UK study suggests – CNN
Comentário no Twitter
The Delta variant is bad enough, but there has been debate as to whether it, per se, carries a higher risk of hospitalization (H) beyond its very high contagiousness. A new, rigorous study shows a doubling of the H rate https://t.co/qom8l6fw4v pic.twitter.com/CwXPOU0YWi
— Eric Topol (@EricTopol) August 27, 2021
Estudo com mais de 2 milhões de pessoas na Inglaterra mostra que a Covid-19, e não a vacinação, apresenta os maiores riscos de coágulos sanguíneos.
30 Ago, 2021 | 13:39hComunicado de imprensa: Covid-19, not vaccination, presents biggest blood clot risks – University of Oxford
Estudo original: Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study – The BMJ
Editorial: Strengthening international surveillance of vaccine safety – The BMJ
Comentários:
Covid: Vaccine complications dwarfed by virus risks – BBC
Comentário no Twitter
#BMJInfographic Fast track research looked at patient level data for ~30 million people vaccinated in England and found that thrombosis risks associated with covid-19 vaccines are lower than that associated with covid-19 infection https://t.co/R0JlcuvMez @JuliaHCox pic.twitter.com/XMzXK6UOBc
— The BMJ (@bmj_latest) August 27, 2021
Nova diretriz do CDC afirma que as vacinas contra influenza e Covid podem ser administradas juntas – “Vacinas contra COVID-19 e outras vacinas agora podem ser administradas sem preocupações quanto ao intervalo entre elas.”
30 Ago, 2021 | 13:33hConteúdo relacionado: Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Authorized in the United States – Centers for Disease Control and Prevention
Comentário: Flu shot and a COVID jab? New 2021-2022 flu vaccine guidance points to both – McKnight’s
M-A | Fatores associados à transmissão domiciliar de SARS-CoV-2 – estudos recentes mostraram taxas maiores de infecção secundária dos contatos domiciliares do que os relatórios prévios (13,4% vs. 31,1%); variantes mais transmissíveis e vacinas podem levar a mudanças futuras.
30 Ago, 2021 | 13:31hComentário: 1 in 5 people with COVID-19 pass it to others in household, study finds – UPI
Comentário no Twitter
The findings of this meta-analysis suggest that the household remains an important site of #SARSCoV2 transmission, and recent studies have higher household secondary attack rates estimates compared with the earliest reports. https://t.co/lFmkaz0zUe
— JAMA Network Open (@JAMANetworkOpen) August 27, 2021
Não é só o SARS-Cov-2: a maioria dos vírus respiratórios é disseminada por aerossóis.
30 Ago, 2021 | 12:59hArtigo original: Airborne transmission of respiratory viruses – Science
Comentário no Twitter (fio – clique para saber mais)
1/ AIRBORNE TRANSMISSION OF RESPIRATORY VIRUSES
A new peer-reviewed paper in @ScienceMagazine, reviewing the scientific literature on this topic. We conclude it is important not just for COVID-19, but also for other respiratory diseases such as the fluhttps://t.co/vik1deBzeB
— Jose-Luis Jimenez (@jljcolorado) August 26, 2021
[Preprint] Dados observacionais sugerem que a imunidade natural conferida pela infecção por SARS-CoV-2 é mais forte e duradoura em comparação à imunidade induzida por vacina.
30 Ago, 2021 | 12:57h
Comentário no Twitter (fio – clique para saber mais)
Interesting and a lot of threads already but I wanna throw a spanner in the works with an annoying question that I hope someone will be able to answer so I can better understand the relevance of this study.https://t.co/5cE0omt6FH
— Andrew L. Croxford (@andrew_croxford) August 26, 2021
[Comunicado de imprensa – Ainda não publicado] Estudo mostra que a proteção vacinal diminui com o tempo, mas as vacinas ainda oferecem uma boa proteção contra doença grave.
30 Ago, 2021 | 12:55hComunicado de imprensa: Is COVID vaccine protection fading? – ZOE Covid Study
Comentários:
Covid infection protection waning in double jabbed – BBC
Estudo de coorte | Maioria dos sobreviventes internados por COVID-19 tiveram boa recuperação física e funcional após 1 ano de seguimento, mas cerca de metade deles mantiveram pelo menos 1 sequela sintomática.
30 Ago, 2021 | 12:53h1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study – The Lancet
Editorial: Understanding long COVID: a modern medical challenge – The Lancet
Conteúdos relacionados:
M-A: More than 50 long-term effects of COVID-19. (vários artigos sobre o tema)
New guidelines to help doctors manage long COVID patients published.
Mucormicose associada a COVID-19: fatores de risco e mecanismos de doença.
30 Ago, 2021 | 12:50hConteúdo relacionado: Clinical Picture: Mucormycosis after COVID-19 in a patient with diabetes. (vários artigos sobre o tema)
Comentário no Twitter
🆕💥💥Review Article #CID @IDSAInfo @jobadd
COVID-19 associated Mucormycosis (CAM): risk factors and mechanisms of disease #IDTwitter #medtwitter #TwitteRx https://t.co/Ob89SFNoPx pic.twitter.com/tzf7KpGVyG— Antibiotic Steward 🆔🇵🇸 Bassam Ghanem (@ABsteward) August 22, 2021
No início, as vacinas contra Covid-19 pareciam beirar a perfeição. A realidade é mais complicada.
30 Ago, 2021 | 12:48hCovid-19 vaccines flirted with perfection at first. Reality is more complicated – STAT
Comentário no Twitter
The mixed blessing of the 95% VE: When Pfizer & Moderna reported late last year that their Covid vaccines were highly effective, our expectations for these vaccines soared. It's time for us to get more realistic about what the vaccines can do. https://t.co/BFpje2qRmS
— Helen Branswell (@HelenBranswell) August 25, 2021